Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2009
10/27/2009US7608731 Phenylacetic acid compounds
10/27/2009US7608721 2-{4-[Ethyl-(thiazol-4-ylmethyl)-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; liver-X-receptor modulators; anticholesterol agents; antiinflammatory agents; atherosclerosis; dyslipidemia; antidiabetic agents; alzheimer's disease; sepsis; skin disorders; cognition modulators
10/27/2009US7608720 Process for the preparation on 2-aminomethylpyridine derivatives
10/27/2009US7608719 Process for the production of heteroaromatic nitriles improved catalyst therefor and a process for the production of said improved catalyst
10/27/2009US7608639 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009CA2567935C Aminopyridine derivatives as selective dopamine d3 agonists
10/27/2009CA2536870C Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
10/27/2009CA2506441C 5-substituted-pyrazine or pyridine glucokinase activators
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009CA2359454C ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
10/27/2009CA2318694C Antivirals
10/22/2009WO2009129267A2 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009WO2009127723A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009WO2009127338A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/22/2009WO2009101432A3 Process for preparing pyridone derivatives
10/22/2009US20090264480 Trpa1 antagonists
10/22/2009US20090264435 Novel Aryl- and Heteroarylpiperazines
10/22/2009US20090264425 Chemical compounds
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009CA2721785A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/21/2009EP2110373A1 Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same
10/21/2009EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009EP1904471B1 Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009EP0900200B9 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/21/2009CN101563325A Process for the synthesis of diaminopyridines from glutaronitriles
10/21/2009CN101560184A N-chiral quaternary ammonium salt derived from amino acid and preparation method thereof
10/21/2009CN101560183A Method for preparing 5-bromo-2-methylpyridine
10/21/2009CN101560182A Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same
10/21/2009CN101560158A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN100551994C Organic electroluminescent devices and metal complex compounds
10/21/2009CN100551532C Method for preparing bisphenol catalysts and bisphenols
10/20/2009US7605259 Structurally rigid dopamine d3 receptor selective ligands and process for making them
10/20/2009US7605164 Compositions and methods for treating heart failure
10/20/2009US7605163 Benzoyl-piperazine derivatives
10/20/2009US7605161 Pyridyl derivatives and their use as therapeutic agents
10/20/2009US7604815 Insecticidal N-substituted (heteroaryl)cycloalkyl sulfoximines
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2380986C Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
10/20/2009CA2364662C 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
10/20/2009CA2336663C Coumarin and related aromatic-based polymeric prodrugs
10/20/2009CA2328832C Processes for preparing pesticidal intermediates
10/20/2009CA2245066C Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents
10/20/2009CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/15/2009WO2009126863A2 Pyridyl inhibitors of hedgehog signalling
10/15/2009WO2009125870A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009124962A2 Sulfonamides
10/15/2009WO2009089284A3 Substituted 2-aminotetralin derivatives as selective alpha 2b agonist
10/15/2009WO2008145615A3 Aminoazoline and urea derivatives for combating animal pests
10/15/2009US20090259042 Electrochromic compounds
10/15/2009US20090258912 N-(1-Alkyl-2-Phenylethyl)-Carboxamide Derivatives and Use Thereof as Fungicides
10/15/2009US20090258911 Composition and method for treating fibrotic diseases
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258905 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
10/15/2009US20090258904 Epithiolone Analogues
10/15/2009US20090258903 Aminoethane Sulfonamide Orexin Receptor Antagonists
10/15/2009US20090258887 Novel Carboxylic Acid Derivatives
10/15/2009US20090258884 Substituted amides
10/15/2009CA2725395A1 Pyridyl inhibitors of hedgehog signalling
10/15/2009CA2720530A1 Sulfonamides
10/14/2009EP2108644A1 N-(methyl)-pyridin-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins
10/14/2009EP1877367B1 Acetylene derivatives
10/14/2009EP1771420B1 Novel 2,6-diaminopyridine-3-one derivatives
10/14/2009EP1729771B1 Pyridyl derivatives and their use as mglu5 receptor antagonists
10/14/2009EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
10/14/2009EP0970050B2 Process for the preparation of 5,6-dihydro-11h-dibenzo a,d cyclohept-11-enes
10/14/2009CN101558041A Caspase inhibitors based on pyridazinone scaffold
10/14/2009CN101555253A Ruthenium polypyridyl complex inducing DNA to condense, preparation method and application thereof
10/14/2009CN101555224A New Etofibrate preparation method
10/14/2009CN100549847C Charge control agent and related technique
10/14/2009CN100549041C Polymerization of ethylene
10/14/2009CN100548987C Pesticidal pyridinecarboxamide derivatives
10/14/2009CN100548986C Cathepsin cysteine protease inhibitors
10/13/2009US7601874 Antiinflammatory agents; antiarthritic agents; brain disorders; multiple sclerosis; gout; inflammatory bowel disorders; gastrointestinal disorders; psoriasis; antiallergens; autoimmune disease
10/13/2009US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2455298C Condensed polycyclic compounds
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/13/2009CA2292775C Cyanoguanidines as cell proliferation inhibitors
10/08/2009WO2009124013A1 Compositions and mehtods for inhibition of hepatocyte growth factory receptor c-met signaling
10/08/2009WO2009123896A1 Pyridyl derivatives as cftr modulators
10/08/2009WO2009123704A2 Process for preparing bis(thiohydrazide amides)
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009122940A1 Method for purification of pyridine, and method for production of chlorinated pyridine
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009WO2009121740A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/08/2009WO2009121704A1 Method for making methylpentamethylene diamine and methylpiperidine
10/08/2009WO2009121484A1 Continuous method for producing amides of aromatic carboxylic acids
10/08/2009US20090253950 Radioactive member and method of making
10/08/2009US20090253914 Process for the preparation of onium salts with dialkylphosphate, dialkylphosphinate or (o-alkyl)alkyl- or alkylphosphonate anions having a low halide content
10/08/2009US20090253913 Process for the preparation of sorafenib and salts thereof
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 633